Patient Navigation Reduces Delays in Diagnostic Resolution

Patient Navigation Reduces Delays in Diagnostic Resolution
Patient Navigation Reduces Delays in Diagnostic Resolution

Patient navigation reduces delays in diagnostic resolution among patients with a Charlson Comorbidity Index (CCI) greater than 1 with abnormal findings on breast, cervical, colorectal, or prostate cancer screening, according to a study published in the journal Cancer.1

Whether patient navigation improves outcomes for patients with comorbidities is unclear. Therefore, researchers sought to evaluate the impact of comorbidities on the time to diagnostic resolution after an abnormal finding on cancer screening test and to assess whether patient navigation shortens time to diagnostic resolution.

For the study, investigators analyzed data from 6439 patients with abnormal findings on breast, cervical, colon, or prostate cancer screening tests between 2007 and 2011 who were included in the Patient Navigation Research Program.

Results showed that patients without navigation and a CCI score of 2 or greater had significantly delayed diagnostic resolution after an abnormal finding on cancer screening test compared with patients with no comorbidities.

However, patients with navigation had an improved time to diagnostic resolution for each CCI score level. Navigated patients with a CCI score of 1 reached diagnostic resolution more quickly than the control group with no comorbidities, while navigated patients with a CCI score of 2 or greater had no delays in diagnostic care as compared with control patients with no comorbidities.

The findings ultimately suggest that patients with multiple chronic diseases may achieve greater benefit from patient navigation after an abnormal finding on cancer screening test.

Reference

1. Whitley EM, Raich PC, Dudley DJ, et al. Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening. Cancer. 2016 Sep 20. doi: 10.1002/cncr.30316. [Epub ahead of print]

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs